Cutaneous metastases from internal malignancies: a clinicopathologic and immunohistochemical review

I Alcaraz, L Cerroni, A Rütten, H Kutzner… - The American journal …, 2012 - journals.lww.com
Skin metastases occur in 0.6%–10.4% of all patients with cancer and represent 2% of all
skin tumors. Skin metastases from visceral malignancies are important for dermatologists …

Pellagra: a review with emphasis on photosensitivity

P Wan, S Moat, A Anstey - British Journal of Dermatology, 2011 - academic.oup.com
Niacin has recently been demonstrated to lower blood pressure in hypertensive patients and
to reduce cardiovascular events when combined with a statin. As a consequence, niacin has …

[HTML][HTML] Guidelines for the diagnosis and management of carcinoid tumours. Part 1: the gastrointestinal tract. A statement from a Canadian National Carcinoid Expert …

J Maroun, W Kocha, L Kvols, G Bjarnason… - Current …, 2006 - pmc.ncbi.nlm.nih.gov
Carcinoid tumours are relatively rare and, in general, slow growing. They can be “non-
functioning” tumours, presenting as a tumour mass, or “functioning” tumours secondary to …

[HTML][HTML] Complications from carcinoid syndrome: review of the current evidence

JM Mota, LG Sousa, RP Riechelmann - Ecancermedicalscience, 2016 - ncbi.nlm.nih.gov
Patients with well-differentiated neuroendocrine tumours may develop carcinoid syndrome
(CS), which is characterised by flushing, abdominal cramps, diarrhoea, and bronchospasms …

Biochemical assessment of niacin deficiency among carcinoid cancer patients

GM Shah, RG Shah, H Veillette… - Official journal of the …, 2005 - journals.lww.com
OBJECTIVE Carcinoid cancer patients often have elevated levels of serotonin or its
precursor 5-hydroxytryptophan. Normally, serotonin synthesis accounts for a small fraction of …

[HTML][HTML] Hormonal crises following receptor radionuclide therapy with the radiolabeled somatostatin analogue [177Lu-DOTA0,Tyr3]octreotate

B de Keizer, MO van Aken, RA Feelders… - European journal of …, 2008 - Springer
Introduction Receptor radionuclide therapy is a promising treatment modality for patients
with neuroendocrine tumors for whom alternative treatments are limited. The aim of this …

Fibrosis and carcinoid syndrome: from causation to future therapy

M Druce, A Rockall, AB Grossman - Nature Reviews Endocrinology, 2009 - nature.com
Carcinoid tumors are part of a heterogeneous group of gastrointestinal and pancreatic
endocrine tumors that are characterized by their capacity to produce and secrete hormones …

Increased expression of 5-hydroxytryptamine2A/B receptors in idiopathic pulmonary fibrosis: a rationale for therapeutic intervention

M Königshoff, R Dumitrascu, S Udalov, OV Amarie… - Thorax, 2010 - thorax.bmj.com
Background Idiopathic pulmonary fibrosis (IPF) has a poor prognosis and limited
responsiveness to available treatments. It is characterised by epithelial cell injury, fibroblast …

Niacin (vitamin B3) supplementation in patients with serotonin-producing neuroendocrine tumor

G Bouma, M van Faassen, G Kats-Ugurlu… - …, 2016 - karger.com
Background/Aims: Tryptophan is the precursor of serotonin and niacin (vitamin B 3). The
latter is critical for normal cellular metabolism. Tryptophan and niacin can be deficient in …

Acquired pigmentary disorders

N van Geel, R Speeckaert - Rook's Textbook of Dermatology …, 2016 - Wiley Online Library
Abnormal skin pigmentation represents a common skin problem which may be congenitally
determined or acquired during life. The former are discussed in Chapter [70]. Acquired …